A. J. Kazimi, Chairman and CEO, 10% Owner at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 168 shares at $5.81 ($807) on 2025-06-13, disclosed to the SEC on 2025-07-11.
Scheduled purchase ($807) by Chairman and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 8 | $42 | 5.2% |
| 2 | $5.61 | 8 | $45 | 5.6% |
| 3 | $5.75 | 8 | $46 | 5.7% |
| 4 | $5.46 | 8 | $44 | 5.4% |
| 5 | $5.57 | 8 | $45 | 5.5% |
| 6 | $5.94 | 8 |
| $48 |
| 5.9% |
| 7 | $6.00 | 8 | $48 | 5.9% |
| 8 | $5.57 | 8 | $45 | 5.5% |
| 9 | $5.67 | 8 | $45 | 5.6% |
| 10 | $5.81 | 8 | $46 | 5.8% |
| 11 | $5.32 | 8 | $43 | 5.3% |
| 12 | $5.61 | 8 | $45 | 5.6% |
| 13 | $5.52 | 8 | $44 | 5.5% |
| 14 | $5.29 | 8 | $42 | 5.2% |
| 15 | $4.61 | 8 | $37 | 4.6% |
| 16 | $3.91 | 8 | $31 | 3.9% |
| 17 | $3.27 | 8 | $26 | 3.2% |
| 18 | $2.71 | 8 | $22 | 2.7% |
| 19 | $2.60 | 8 | $21 | 2.6% |
| 20 | $2.74 | 16 | $44 | 5.4% |
| Total | $4.80 avg | 168 | $807 | 100% |
| Filing → |
| CPIX | BUY | 2025-06-06 | $858 | — | Filing → |
| CPIX | BUY | 2025-05-09 | $833 | — | Filing → |
| CPIX | BUY | 2025-04-04 | $881 | — | Filing → |